US Annualised CPI (June): Headline 3m 2.784% (prev. 8.204%), 6m 4.050% (prev. 5.561%); Core 3m 2.294% (prev. 3.166%), 6m 2.579% (prev. 3.091%)
Newsquawk Staff ·
- This is available under the Newsquawk V2 Widget: US Macro Data
- PRE-MARKET CHINESE STOCKS NEWS: Earnings from China Telecom and Chow Tai fook
- OpenAI is raising up to USD 30bln in funding round at a USD 1.25tln valuation, led by UAE investors, according to CNBC, citing sources; OpenAI is negotiating a commercial deal that would secure more computing capacity from the UAE
- Western Digital (WDC) Q1 2027 (USD): Adj. EPS 4.64 (exp. 4.08), Revenue 4.38bln (exp. 4.14bln)
- US TREASURY WRAP: T-NOTE FUTURES (Z6) SETTLE 1 POINT AND 9+ TICKS HIGHER AT 106-13
- US EQUITY OPEN: Mag-7 earnings lead Tech and Indices lower as the Middle East situation remains fragile
Related headlines
- Newsquawk Daily Economic Releases - 23rd October 202614 hours ago
- US Initial Jobless Claims (Oct/17) 194K vs. Exp. 200K (Prev. 200K)15 hours ago
- Tesla (TSLA) has decided not to proceed with plans to produce Cybertruck for Australia and New Zealand3 hours ago
- OpenAI trims valuation target to USD 1.25tln after previously pitching a higher price, according to FT5 hours ago
- Newmont (NEM) says production growth is expected to begin in 2027 following previously flagged 2026 trough, adds Q3 gold production was broadly flat sequentially as anticipated6 hours ago
- SpaceX (SPCX) in talks to access 80,000 cell sites for new network6 hours ago
- Google (GOOG) announces general availability of an Anthropic-managed deployment option for Claude models on Google Cloud6 hours ago
- Gilead Sciences (GILD) entered into a definitive agreement to acquire an oral IL-23R inhibitor program, including lead asset HCXT-2001, from PepStar Therapeutics Limited; deal valued at USD 1.27bln in upfront cash7 hours ago
- Newmont (NEM) Q3 2026 (USD): Adj. EPS 2.20 (exp. 2.06), Revenue 6.36bln (exp. 6.30bln), Adj. EBITDA 3.95bln (exp. 3.73bln)7 hours ago
- Bloom Energy (BE) Q3 2026 (USD): Adj. EPS 0.94 (exp. 0.69), Revenue 1.24bln (exp. 1.06bln)7 hours ago
- Merck & Co (MRK) and Moderna (MRNA) say safety profile of Intismeran plus Keytruda was generally consistent with previously reported studies of combination; significantly reduced the risk of recurrence or death by 42% compared to Keytruda alone9 hours ago
- DataDog (DDOG) recently offered almost USD 4bln to acquire Upwind Security, but the Co. hasn't accepted the offer, reports The Information citing sources10 hours ago
- Statnews posts on X, "Rumors are swirling that the Treasury Department this week is going to propose a rule that restricts U.S. investment in the Chinese biotech sector"11 hours ago
- Moderna (MRNA) downside attributed to early data leaks (link below) - UNCONFIRMED11 hours ago
- State of Rhode Island sues Meta (META) over alleged tolerance for scam advertising11 hours ago